Bayer Names Julio Triana President of Consumer-Health Division
By Mauro Orru
Bayer appointed Julio Triana as president of its consumer-health division, taking the reins from Heiko Schipper after he asked the company to bring forward the end date of his contract to pursue a career opportunity outside of Bayer.
The German pharmaceutical and agricultural conglomerate said Thursday that Triana, currently head of international commercial operations at Bayer's pharmaceuticals division, would assume his new role on May 1. However, he will be part of Bayer's management board effective April 1.
He joined Bayer in 2002, and served in roles spanning finance, strategy and business development.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
February 29, 2024 11:28 ET (16:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?